WeSearch

STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

Ed Silverman· ·1 min read · 0 reactions · 0 comments · 23 views
STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

Eli Lilly reported that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a Phase 1 clinical trial

Original article
STAT · Ed Silverman
Read full at STAT →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT

Nonprofit buys experimental cancer drug to maintain patient access
STAT·9
Study highlights influence of socioeconomic status on children’s brain development
STAT·7
STAT+: Abridge inks deals with Nvidia and Lilly
STAT·6
STAT+: Novartis doubles down on molecular glue strategy
STAT·8
Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850
STAT·14
Opinion: How long Covid’s scientific stalemate made it politically erasable
STAT·13